BONNIE OGDEN: Open Payments
NPI 1144254046 · CHESTERFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 27 payments from 12 companies in 2025. Trend: 2023 $572 · 2024 $630 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $100 |
| Novo Nordisk Inc | 5 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Amgen Inc. | 4 | $60 |
| ABBVIE INC. | 2 | $49 |
| ALK-Abello, Inc | 2 | $38 |
| Exact Sciences Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Electromed, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: XIFAXAN, JARDIANCE, Wegovy, QULIPTA, REPATHA, Rybelsus, MOUNJARO, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
